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data analysis is becoming the standard and new comparison 
metrics are extracted from it [2]. 
Materials and Methods: Our study was done in 40 IMRT step 
and shoot treatments, mostly head and neck location. The 
plans were calculated with the TPS PCRT 6.0 (Tecnicas 
Radiofisicas) using SCC. A MC homemade software application 
called ‘’MCVerif‘, based on BEAMnrc, is used for dose 
redundant calculation for RT beams from our linac Oncor 
Impression (Siemens). Our routine automates the 
input/output process and allows displaying the result in the 
TPS, including DVH. MU were matched in both calculated 
plans (SCC/MC) and differential DVH were generated to 
analyze the found differences, and processed by a homemade 
software application in order to get different parameters 
like: volume average dose, V95, D95, D2 which are 
considered representatives for the target volumes (PTV and 
CTV), average dose and volumes at dose limits for parallel 
organs at risk (OAR), and D0.1cc for serial OARs. Statistical 
exploratory analysis for the differences in relevant clinical 
parameters was performed with SPSS 15.0. 
Results: We present a data table with relevant statistical 
results for the main PTV and the following OARs: spinal cord, 
parotid glands and lenses. The differences in % are relative to 
the MC calculation. The PTV and parotid glands average doses 
pass the Saphiro-Wilk normality tests. In addition, a similar 
concept to that established in the ESTRO booklet nº10 [3] can 
be applied to average doses in order to set an action level for 
the verification in redundant calculations. Following this 
formalism, our results for the average doses in terms of mean 
difference and standard deviation are satisfactory. For the 
spinal cord, D0.1 cc agrees consistently between both 
algorithms. For the lenses, D0.1cc is in general lower for MC 
than for SCC, suggesting discrepancy between both 
algorithms when calculating the out of field dose. Differences 
found in the analysis can be considered acceptable in terms 
of clinical relevance.  
Conclusions: Good agreement has been found between SCC y 
MC results. MC verification has been validated as 
independent dose calculation method in addition to 
experimental measurements at the LINAC. 
This method focuses on dose distribution differences which 
may have clinical impact and has clear advantages compared 
to the gamma tool. The development of new metrics for IMRT 
evaluation is work in progress in our department. 
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Purpose/Objective: To evaluate single-isocenter treatment 
using Brainlab Automated Brain Metastases Treatment 
Planning software (BBM), a novel technique for radiosurgery 
of multiple brain metastases, and to compare these with 
VMAT, Gammaknife and conventional multi-isocenter 
techniques with respect to plan quality and time-
consumption (planning and application). 
Materials and Methods: Treatment plans were created for 
different patients with 4-8 metastases using the BBM 
Software. This is a novel automatic solution that uses a single 
isocenter in combination with up to five table angles. The 
contoured datasets were exported and used to create plans 
using VMAT, Gammaknife and conventional multi-isocenter 
techniques (dynamic conformal arcs or conformal beams). All 
plans were calculated using the same prescription and 
fractionation and were analyzed with respect to the inversed 
Paddick conformity index (PCI), the gradient index (GI), the 
dose spillage (mean, V12Gy, V8Gy, V4Gy), total monitor units 
and planning time and delivery time.  
Results: BBM achieved conformal plans (PCI= 1.44 ± 0.21) 
with steep dose fall-off (GI= 3.98 ± 0.49) and very low dose 
spillage in a very short time (approx. 10 minutes). VMAT 
plans had comparable conformity (PCI), worse gradient index 
(GI) and significantly higher dose spillage. The amount of 
monitor units compared to BBM was almost doubled. Planning 
time was higher (1.5 hours up to 3 hours depending on the 




Figure 1 shows a comparison of a BBM plan (right) with a 
VMAT plan (left) with respect to the dose spillage and 
conformity. 24 Gy were prescribed to the 8 metastases. Four 
of these lesions can be identified in this CT slices. For VMAT, 
the areas with up to 12 Gy can not be separated. Almost the 
whole brain receives 3 Gy and more when using VMAT.  
The conventional multi-isocenter techniques created plans 
with comparable plan quality (PCI, GI and dose spillage). 
Planning time was equivalent to VMAT. The delivery time was 
dependent on the number of lesions and isocenters used. It 
can be calculated by multiplying the delivery time for BBM by 
the number of isocenters. The same equation can be applied 
to calculate the amount of monitor units required for the 
conventional techniques. The Gammaknife plans had a 
comparable plan quality. Nevertheless the time consumed to 
create a plan and to delivery this plan is much higher 
compared to the BBM plans. 
Conclusions: All four techniques achieved conformal plans 
(PCI). The plans created with BBM had lower dose spillage 
and steeper dose dose-off from targets than VMAT. Compared 
to conventional multi-isocenter techniques and Gammaknife 
the BBM plans similar plan quality but were more efficient to 
delivery. The planning process for BBM plans was faster (10 
min. vs. 1.5 to 3 hours) compared to all other techniques. 
BBM is a very fast, efficient and easy to use solution to 
achieve high conformal plans for patients with multiple brain 
metastases.  
   
